On Feb. 24, 2021, XPhyto announced that it has placed the first order for its rapid point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system (“Covid-ID Lab”) from its exclusive diagnostic development partner, 3a-diagnostics.

The first order of Covid-ID Lab was for 9,600 individual tests which were packaged in 200 kits of 48 tests each. Delivery of the first order was expected by mid-March 2021 and primarily used to supply prospective distribution partners and licensees and their respective government regulators with tests samples for review and evaluation.